𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Re: Impact of screening on survival for hepatocellular carcinoma

✍ Scribed by Stuart Roberts

Book ID
108950706
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
47 KB
Volume
21
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of pretransplantation transarteri
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
✍ Thomas Decaens; FranΓ§oise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-

Mammographic screening: Patterns of use
Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival
✍ Karen Blanchard; James A. Colbert; Dhruv Puri; Joel Weissman; Beverly Moy; Danie πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 213 KB

## Background: Although many studies support the life-saving potential of screening mammography, the actual utilization of screening and the impact of the actual pattern of screening use on the breast carcinoma death rate, remain incompletely understood. in the current report, the authors describe

Screening methods for early detection of
Screening methods for early detection of hepatocellular carcinoma
✍ Kenichi Kobayashi; Tatsuho Sugimoto; Hiroshi Makino; Mikio Kumagai; Masashi Unou πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 629 KB

The value of various screening methods in the detection of early hepatocellular carcinoma was investigated in 95 patients with cirrhosis. Infusion hepatic angiography and computed tomography with angiography were performed yearly, ultrasound every 3 months, and determination of serum alpha-fetoprote